Using AI to Diagnose Solid Pancreatic Lesions
Official title: 内镜超声穿刺胰腺实性占位细胞涂片快速染色后全玻片扫描及人工智能诊断:一项前瞻性、多中心研究
Run by Ruijin Hospital · NCT06824909 · Data updated 2026-11-12
This study is testing a new AI system to see if it can help doctors better and faster diagnose solid pancreatic lesions during an ultrasound procedure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 2 sites (Shanghai, Shanghai Municipality and 1 other locations) |
| Status | Recruiting |
| Started | December 31, 2024 |
| Main results expected | May 31, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | February 13, 2025 |
| Trial ID | NCT06824909 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and above with a diagnosis or suspicion of solid pancreatic lesions based on imaging studies.
✕Probably not a fit
Patients with pancreatic cystic lesions or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of a self-developed artificial intelligence diagnostic system, known as the ROSE-AI system, in diagnosing solid pancreatic lesions through endoscopic ultrasound-guided fine-needle aspiration. The study will utilize optical imaging technology to capture images of stained cytological smears and compare the AI-generated diagnoses with actual pathological results. By focusing on differentiating various pancreatic diseases, including pancreatic ductal adenocarcinoma and neuroendocrine tumors, the study seeks to improve diagnostic accuracy and speed.
Why it matters
Potential benefit: If successful, this study could lead to faster and more accurate diagnoses of pancreatic diseases, improving patient outcomes.
How similar studies have gone: Other studies have shown promise in using AI for diagnostic purposes, but this specific approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A dated and signed informed consent form A commitment to abide by the research procedures and cooperate throughout the entire study Subjects aged 18 and above, regardless of gender Diagnosis or suspicion of a solid pancreatic space-occupying lesion based on imaging studies (B-mode ultrasound, CT, or MRI) Exclusion Criteria: * Unable or refusing to sign the informed consent form Unable to suspend anticoagulation/antiplatelet therapy Pregnant or lactating Having a mental illness or other medical conditions that are unsuitable for undergoing FNA/B biopsy Presence of coagulation disorders (PLT \< 50 × 10\^3/μl, INR \> 1.5) Pancreatic cystic lesions Non-diagnostic EUS-FNA/B specimens Having less than 8 microscopic fields of interest (ROI) in the digital pathology images of the entire Diff-Quik smear slide
Where it's running
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China Recruiting -
Department of Gastroenterolog, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis
We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.
-
Evaluating pancreatic fistula rates after surgery using a specific stapler
This study is testing if using a specific stapler during pancreas surgery can lower the chances of complications like pancreatic fistulas in patients.
-
Creating a biobank for studying bilio-pancreatic diseases
This study is creating a collection of biological samples and health information to see how genes and environment affect the risk of bilio-pancreatic diseases.
-
Comparing two methods for examining gastrointestinal lesions
This study is testing whether a new imaging system for examining gastrointestinal lesions works better than the standard method for people undergoing endoscopic ultrasound.
-
Using AI to improve pancreatic ultrasound scanning
This study is testing whether a new AI system can help doctors do pancreatic ultrasound scans more accurately and quickly.
-
Investigating the impact of being a CF carrier on kidney and pancreatic health
This study is trying to see if people who carry the cystic fibrosis gene are at a higher risk for kidney and pancreatic diseases compared to others.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.